-
Something wrong with this record ?
Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients
M. Beránek, V. Koblížek, P. Dulíček, J. Hegerová, V. Palička
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- COVID-19 * diagnosis genetics MeSH
- DNA MeSH
- Factor V genetics MeSH
- Real-Time Polymerase Chain Reaction MeSH
- Humans MeSH
- Mutation MeSH
- Prothrombin genetics MeSH
- Risk Factors MeSH
- SARS-CoV-2 genetics MeSH
- COVID-19 Testing MeSH
- Thrombophilia * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
High incidence of thrombosis and venous thromboembolism was reported in patients with COVID-19. In this study, we focused on analysis of thrombophilic mutations performed without a standard DNA extraction step. In one hundred of COVID-19 positive outpatients, real-time PCR for Leiden mutation in the FV gene and G20210A mutation in the FII gene was carried out from DNA extracts and modified whole blood samples, and their cycle threshold (Ct) values were evaluated. In the extracts, healthy homozygotes (wt/wt), heterozygotes (M/wt), and homozygous carriers of Leiden mutation (M/M) provided median Ct values of 18.5, 19.4/22.0, and 20.9. In the whole blood, Ct values were 25.3 (wt/wt), 24.8/27.2 (M/wt), and 26.9 (M/M). Median Ct values for G20210A in the extracts were 19.6 for homozygotes (wt/wt), and 19.7/20.4 for heterozygous carriers. The whole blood samples provided Ct values of 23.9 in healthy homozygotes and 26.3/27.2 in heterozygotes for G20210A mutation. No homozygous subjects for G20210A and no double heterozygotes (for Leiden and G20210A mutations) were found. Despite significant differences in the Ct values, genotyping showed complete result concordance of the DNA extracts and the whole blood samples. The integrity and amplificability of DNA molecules in the whole blood samples during 28 days of deep freezing, interrupted by four cycles of thawing, did not significantly change. In conclusion, we demonstrated a new protocol for the detection of the thrombophilic mutations via real time PCR on the modified whole blood of COVID-19 positive patients. The blood modification was reliable, easy, cheap, and saving costs and turnaround time of the whole laboratory process.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22021450
- 003
- CZ-PrNML
- 005
- 20230517093529.0
- 007
- ta
- 008
- 220907s2022 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934883 $2 doi
- 035 __
- $a (PubMed)35616044
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Beránek, Martin, $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $d 1968- $7 xx0044204
- 245 10
- $a Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients / $c M. Beránek, V. Koblížek, P. Dulíček, J. Hegerová, V. Palička
- 520 9_
- $a High incidence of thrombosis and venous thromboembolism was reported in patients with COVID-19. In this study, we focused on analysis of thrombophilic mutations performed without a standard DNA extraction step. In one hundred of COVID-19 positive outpatients, real-time PCR for Leiden mutation in the FV gene and G20210A mutation in the FII gene was carried out from DNA extracts and modified whole blood samples, and their cycle threshold (Ct) values were evaluated. In the extracts, healthy homozygotes (wt/wt), heterozygotes (M/wt), and homozygous carriers of Leiden mutation (M/M) provided median Ct values of 18.5, 19.4/22.0, and 20.9. In the whole blood, Ct values were 25.3 (wt/wt), 24.8/27.2 (M/wt), and 26.9 (M/M). Median Ct values for G20210A in the extracts were 19.6 for homozygotes (wt/wt), and 19.7/20.4 for heterozygous carriers. The whole blood samples provided Ct values of 23.9 in healthy homozygotes and 26.3/27.2 in heterozygotes for G20210A mutation. No homozygous subjects for G20210A and no double heterozygotes (for Leiden and G20210A mutations) were found. Despite significant differences in the Ct values, genotyping showed complete result concordance of the DNA extracts and the whole blood samples. The integrity and amplificability of DNA molecules in the whole blood samples during 28 days of deep freezing, interrupted by four cycles of thawing, did not significantly change. In conclusion, we demonstrated a new protocol for the detection of the thrombophilic mutations via real time PCR on the modified whole blood of COVID-19 positive patients. The blood modification was reliable, easy, cheap, and saving costs and turnaround time of the whole laboratory process.
- 650 12
- $a COVID-19 $x diagnóza $x genetika $7 D000086382
- 650 _2
- $a testování na COVID-19 $7 D000086742
- 650 _2
- $a DNA $7 D004247
- 650 _2
- $a faktor V $x genetika $7 D005165
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a protrombin $x genetika $7 D011516
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a SARS-CoV-2 $x genetika $7 D000086402
- 650 12
- $a trombofilie $x genetika $7 D019851
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Koblížek, Vladimír, $d 1970- $7 xx0076215 $u Department of Pneumology, Charles University Hospital and Faculty of Medicine in Hradec Králové, Czech Republic
- 700 1_
- $a Dulíček, Petr, $u Fourth Department of Internal Medicine, Charles University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $d 1960- $7 nlk20030127854
- 700 1_
- $a Hegerová, Jaroslava $7 xx0183352 $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Palička, Vladimír, $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $d 1946- $7 jn99240000830
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 3 (2022), s. 439-445
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35616044 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20220907 $b ABA008
- 991 __
- $a 20230517093525 $b ABA008
- 999 __
- $a ok $b bmc $g 1851680 $s 1172718
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 71 $c 3 $d 439-445 $e 20220526 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20220907